Co-injection either wild-type (WT) or kinase-dead (KD) c-Met, along with HHLA2 or control vector, demonstrated HHLA2 enhanced tumor growth in WT c-Met mice but not in KD c-Met mice (Fig. 4G). The gene discussed is MET; the disease is neoplasm.